Influence of adjuvants on the ability of anti-Tbp antibodies to block transferrin binding, iron uptake and growth of Neisseria meningitidis;Influencia de adyuvantes en la capacidad de los anticuerpos anti-Tbps de bloquear la unión de transferrina, la asimilación de hierro y el crecimiento en Neisseria meningitidis

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 20, Issue 7, 2002, Pages 316-320

  Ferreirós, Carlos ^a   Ferreiro, Nuria ^a   Criado, M T ^a  

^a Universidade de Santiago de Compostela   (Spain)

Author keywords

Adjuvants; Neisseria meningitidis; Transferrin binding proteins

Indexed keywords

ADJUVANT; BINDING PROTEIN; IRON; IRON BINDING PROTEIN; PROTEIN ANTIBODY; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL GROWTH; ENZYME LINKED IMMUNOSORBENT ASSAY; IRON TRANSPORT; MOUSE; NEISSERIA; NEISSERIA MENINGITIDIS; NONHUMAN; PROTEIN BINDING; STRAIN DIFFERENCE;

EID: 0036695486     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0213-005x(02)72807-3     Document Type: Article

References (22)

1. Ramsay ME, Andrews N, Kaczmarski EB, Miller E. Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England. Lancet 2001;357:195-6.
2. Schryvers AB, Morris LJ. Identification and characterization of the human lactoferrin-binding protein from Neisseria meningitidis. Infect Immun 1988;56:1144-9.
3. Schryvers AB, Lee BC. Comparative analysis of the transferrin and lactoferrin binding proteins in the family Neisseriaceae. Can J Microbiol 1989;35: 409-15.
4. Ferrón L, Ferreirós CM, Criado MT, Andrade MP. Purification of the Neisseria meningitidis transferrin binding protein-2 (Tbp2) to homogeneity using column chromatography. FEMS Microbiol Lett 1993;109:159-66.
5. Pettersson A, Klarenbeek V, Van Deurzen J, Poolman JT, Tommassen J. Molecular characterization of the structural gene for the lactofferin receptor of the meningococcal strain H44/76. Microb Pathog 1994;17:395-408.
6. Lissolo L, Maitre-Wilmotte G, Dumas P, Mignon M, Danve B, Quentin-Millet MJ. Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun 1995;63:884-90.
7. Pintor M, Ferron L, Gomez JA, Gorringe A, Criado MT, Ferreiros CM. Blocking of iron uptake by monoclonal antibodies specfic for the Neisseria meningitidis transferrin-binding protein 2. J Med Microbiol 1996a;45:252-7.
8. Pintor M, Ferron L, Gomez JA, Powell NBL, Ala'Aldeen DAA, Borriello SP, et al. Blocking of iron uptake from transferrin by antibodies against the transferrin binding proteins in Neisseria meningitidis. Microb Pathog 1996;20:127-39.
9. Morse SA, Bartenstein L. Purine metabolism in Neisseria gonorrhoeae: the requeriment for hypoxanthine. Can J Microbiol 1980;26:13-20.
10. Pintor M, Ferreiros CM, Criado MT. Characterization of the transferrin-iron uptake system in Neisseria meningitidis. FEMS Microbiol Lett 1993;12: 150-66.
11. Gomez JA, Criado MT, Ferreiros CM. Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37 kDa ferric binding protein (FbpA) with different adjuvants. FEMS Immunol Med Microbiol 1998;20: 79-86.
12. Pintor M, Ferreirós CM, Criado MT. Energy-independent binding of iron complexed to samll organic chelants by Neisseria meningitidis. J Gen Appl Microbiol 1994;40:23-4.
13. Pintor M, Ferreiros CM, Criado MT, Ferron L. Expression levels of human transferrin receptors in Neisseria species. J Microbiol Meth 1992;15:321-6.
14. Simonson C, Brener D, DeVoe IW. Expression of a high-affinity mechanisms for acquisition of transferrin iron by Neisseria meningitidis. Infect Immun 1982;36:159-66.
15. a ed. New York: WH Freeman and Company, 1995; p. 207-1.
16. A'Aldeen DAA, Borriello SP. The meningococcal transferrin-binding proteins 1 and 2 are both surface exposed and generate bactericidal antibodies capable of killing homologous and heterologous strains. Vaccine 1996;14: 49-53.
17. Ferron L, Ferreiros CM, Criado MT, Pintor M. Reliability of laboratory models in the analysis of TbpB and other meningococcal antigens. FEMS Immunol Med Microbiol 1994;9:299-306.
18. Rokbi B, Mazarin V, Maitre-Wilmotte G, Quentin-Millet MJ. Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol Lett 1993;110:51-8.
19. Ferron L, Ferreiros CM, Criado MT, Pintor M. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis. Infect Immun 1992;60:2887-92.
20. Ala'Aldeen DAA, Stevenson P, Griffiths E, Gorringe AR, Irons LI, Robinson A, et al. Immune responses in humans and animals to meningococcal transferrin-binding proteins: Implications for vaccine design. Infect Immun 1994;62:2984-90.
21. Gupta RK, Siber GR. Adjuvants for human vaccines current status, problems and future prospects. Vaccine 1995;13:1263-76.
22. Gomez JA, Hernandez E, Criado MT, Ferreiros CM. Effect of adjuvant in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis. Vaccine 1998;16:1633-9.